×
About 6,718 results

ALLMedicine™ Viral Hepatitis Center

Research & Reviews  2,203 results

Present and future management of viral hepatitis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704279
World Journal of Gastroenterology; González Grande R, Santaella Leiva I et. al.

Jan 25th, 2022 - Viral hepatitis can result in important morbidity and mortality, with its impact on health conditioned by the specific type of hepatitis, the geographical region of presentation and the development and access to new drugs, among other factors. Mos...

Progress on global hepatitis elimination targets.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704269
World Journal of Gastroenterology; Waheed Y

Jan 25th, 2022 - In 2016, the World Health Assembly adopted a Global Health Sector Strategy on viral hepatitis, with targets set for the years 2020 and 2030 to achieve hepatitis elimination. The main target of hepatitis elimination strategy is to reduce the incide...

The Burden of NAFLD in Type 2 Diabetic Subjects from the General Population: a Nationwi...
https://doi.org/10.1111/liv.15171
Liver International : Official Journal of the Internation... Nabi O, Boursier J et. al.

Jan 24th, 2022 - The epidemiology and natural history of NAFLD in diabetes have been mainly investigated in the hospital setting. The goal of this study was to evaluate the characteristics of NAFLD and its impact on morbidity and mortality in type 2 diabetic subje...

Cost-effectiveness of universal screening for chronic hepatitis B virus infection in Ch...
https://doi.org/10.1016/S2214-109X(21)00517-9
The Lancet. Global Health; Su S, Wong WC et. al.

Jan 23rd, 2022 - China has the highest prevalence of hepatitis B virus (HBV) infection worldwide. Universal HBV screening might enable China to reach the WHO 2030 target of 90% diagnostics, 80% treatment, and 65% HBV-related death reduction, and eventually elimina...

see more →

Guidelines  9 results

Cancer immunotherapy in special challenging populations: recommendations of the Advisor...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009216
Journal for Immunotherapy of Cancer; Gonzalez-Cao M, Puertolas T et. al.

Mar 31st, 2021 - Cancer immunotherapy based on the use of antibodies targeting the so-called checkpoint inhibitors, such as programmed cell death-1 receptor, its ligand, or CTLA-4, has shown durable clinical benefit and survival improvement in melanoma and other t...

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specifi...
https://doi.org/10.1111/jdv.16926
Journal of the European Academy of Dermatology and Venere... Nast A, Smith C et. al.

Feb 7th, 2021 - This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The second part of the guideline provides guidance for specific clini...

Joint Society statement for elimination of viral hepatitis.
https://doi.org/10.5604/16652681.1226808
Annals of Hepatology; Brahm J, Castera L et. al.

Jan 5th, 2017 - Joint Society statement for elimination of viral hepatitis.|2017|Brahm J,Castera L,Hou J,Lindor K,|standards,diagnosis,mortality,prevention & control,virology,standards,standards,standards,

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
https://doi.org/10.1038/ajg.2016.517
The American Journal of Gastroenterology; Kwo PY, Cohen SM et. al.

Dec 21st, 2016 - Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests sh...

Who to test and how to test for chronic hepatitis C infection - 2016 WHO testing guidan...
https://doi.org/10.1016/j.jhep.2016.08.002
Journal of Hepatology; Easterbrook PJ,

Sep 20th, 2016 - Testing and diagnosis of hepatitis C virus (HCV) infection is the gateway for access to both treatment and prevention services, and crucial for an effective hepatitis epidemic response. In contrast to HIV, a systematic approach to hepatitis C test...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  81 results

Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University Hospital
https://clinicaltrials.gov/ct2/show/NCT04959643

Jan 10th, 2022 - Context : Even if the rate of under-screening for viral hepatitis B and C is getting better, the situation is still concerning. In France, it has been estimated that about 100 000 people have a positive serology for hepatitis C, and that 75,000 ar...

Hepatitis C Screening Paired With Mammography
https://clinicaltrials.gov/ct2/show/NCT05067374

Jan 5th, 2022 - Context : Organized breast cancer screening has been introduced in France since 2004. It concerns women aged 50 to 74 years old with average risk (no symptoms and no risk factors). This systematic screening reaches approximately 70% of the includa...

An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis
https://clinicaltrials.gov/ct2/show/NCT03656068

Dec 29th, 2021 - Based on the anti-fibrotic properties demonstrated in the animal models of fibrosis, this proof of concept clinical study aims at evaluating NTZ in patients with non-alcoholic steatohepatitis (NASH) and fibrosis stage 2 and 3. Although NTZ has bee...

Screening Protocol for the Evaluation of Potential Research Subjects
https://clinicaltrials.gov/ct2/show/NCT01036971

Dec 28th, 2021 - This protocol describes the screening process used by the National Institute on Drug Abuse (NIDA IRP) to assess potential research participants' eligibility for entering protocols of the NIDA/IRP. Through its clinical research protocols, the IRP a...

A Multi-Center Trial to Study Acute Liver Failure in Adults
https://clinicaltrials.gov/ct2/show/NCT00518440

Dec 27th, 2021 - Although ALF is truly an orphan disease affecting only about 2,000 persons per year, its severity, its frequency among young adults, and its high resource utilization justifies the attention paid to it. In addition, ALF has captured the interest a...

see more →

News  381 results

Simple Model Helps Predict ESLD in People Living With HIV
https://www.medscape.com/viewarticle/965810

Jan 4th, 2022 - NEW YORK (Reuters Health) - Researchers from the U.S. and Canada have teamed up to develop and validate a model for predicting end-stage liver disease (ESLD) in people living with HIV (PWH). "This model of readily accessible clinical parameters pr...

FIB-4 Could ID Liver Risk in Primary Care
https://www.medscape.com/viewarticle/964659

Dec 13th, 2021 - Fibrosis-4 index (FIB-4) scores are strongly associated with severe liver disease outcomes in a primary care population, both in patients with known chronic liver disease and those without known CLD. The result could help identify patients with CL...

Bulevirtide Shows Real-World Efficacy Versus HDV
https://www.medscape.com/viewarticle/964617

Dec 10th, 2021 - A real-world analysis of bulevirtide found a safety and efficacy profile similar to what was seen in earlier clinical trials in the treatment of hepatitis delta virus (HDV) infection. HDV can only infect patients already carrying hepatitis B virus...

Biden Unveils Plan to Hasten 'End' of HIV Epidemic
https://www.medpagetoday.com/hivaids/hivaids/95967

Dec 1st, 2021 - President Biden announced a new National HIV/AIDS strategy that he described as "a roadmap for how we're going to put our foot on the gas, and accelerate our efforts to end the HIV epidemic in the United States by the year 2030." On World AIDS Day...

NAFLD, ALD Prevalent Among Teens, Young Adults
https://www.medscape.com/viewarticle/963363

Nov 19th, 2021 - Two fifths of adolescents and young adults in the United States may have nonalcoholic fatty liver disease (NAFLD), many with significant or advanced fibrosis, results of a nationwide surveillance study suggest. In addition, among those who drink a...

see more →

Patient Education  10 results see all →